Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: Eight million in England To Face Toughest Virus Restrictions

Mon, 26th Oct 2020 18:57

(Alliance News) - More than eight million people in England will be under the most stringent coronavirus restrictions when Nottingham and Warrington move into Tier 3 this week.

Tougher measures will come into force in the Midlands city and the boroughs of Broxtowe, Gedling and Rushcliffe on Thursday, with details expected to be set out on Tuesday.

It came just hours after it was confirmed that Warrington will enter Tier 3 on Tuesday, with pubs and bars in the Cheshire town having to close unless they serve substantial meals.

Households will be banned from mixing indoors or in private gardens and beer gardens, while betting shops, adult gaming centres, casinos and soft play centres will also close.

Warrington Borough Council will receive a financial support package of GBP1.7 million to help contact tracing and enforcement, as well as GBP4.2 million in business support from the UK government.

The two areas will join the Liverpool City Region, Greater Manchester, Lancashire and South Yorkshire in Tier 3, placing 8.2 million people in England under the toughest restrictions.

The rate of coronavirus cases in Nottingham fell from 726.6 in the seven days to October 15 to 464.4 in the week to October 22, with 1,546 new cases, according to analysis by the PA news agency.

But in Warrington cases rose from 343.3 to 395.2 per 100,000 people over the same period, with 830 new cases.

In a joint statement, Nottingham City Council and Nottinghamshire County Council said the measures had been agreed to "achieve a sustained reduction in infection rates, especially to help protect our vulnerable residents, the NHS and social care services".

"A package of support similar to those secured in other parts of the country has been agreed to help residents and businesses who will be impacted by the new restrictions."

Earlier, Health Secretary Matt Hancock said it was "time to take action" in Warrington with rising infection rates.

"I know that these new measures will mean sacrifices must be made by the people in Warrington, and I want to extend my thanks to each and every one of them for recognising the severity of the situation and sticking to the rules.

"We have agreed a support package designed to help businesses while boosting efforts to control the virus locally, and will not hesitate to take similar action in any area of the country if infection rates continue to rise.

"Please remember – now is the time for us all to work together to get this virus under control."

And he told the BBC that areas under Tier 3 restrictions would have to prove that their infection rate was "coming down", especially among those aged 60 or over, before they could be removed from the strictest measures.

Mr Hancock has also refused to rule out bringing in a tougher set of Tier 4 impositions following reports another level is being considered to tackle England's rise in infections.

In other developments, Boris Johnson insisted the government would not allow children to go hungry amid mounting anger over his refusal to extend free school meals during the half-term break.

The government also said a further 102 people had died within 28 days of testing positive for Covid-19 as of Monday, while there were a further 20,890 lab-confirmed cases of coronavirus in the UK.

Elsewhere, the Oxford University and AstraZeneca PLC Covid-19 vaccine shows a "strong immune response" among elderly participants, according to experts.

Meanwhile, the Welsh government explained it will "continue to learn lessons" about how it communicates its lockdown rules following confusion over a ban on selling non-essential items.

source: PA

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.